Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Transdermal Patches Market, by End User
1.4.2 North America Transdermal Patches Market, by Distribution Channel
1.4.3 North America Transdermal Patches Market, by Adhesive Type
1.4.4 North America Transdermal Patches Market, by Patch Type
1.4.5 North America Transdermal Patches Market, by Application
1.4.6 North America Transdermal Patches Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
Chapter 4. Competition Analysis – Global
4.1 Market Share Analysis, 2022
4.2 Porter’s Five Forces Analysis
Chapter 5. North America Transdermal Patches Market by End User
5.1 North America Homecare Settings Market by Region
5.2 North America Hospitals & Clinics Market by Region
Chapter 6. North America Transdermal Patches Market by Distribution Channel
6.1 North America Hospital Pharmacies Market by Country
6.2 North America Retail Pharmacies Market by Country
6.3 North America Online Pharmacies Market by Country
Chapter 7. North America Transdermal Patches Market by Adhesive Type
7.1 North America Acrylic Adhesives Market by Country
7.2 North America Silicone Adhesives Market by Country
7.3 North America Hydrogel Adhesives Market by Country
7.4 North America Others Market by Country
Chapter 8. North America Transdermal Patches Market by Patch Type
8.1 North America Drug-In-Adhesive Market by Country
8.2 North America Matrix Patches Market by Country
8.3 North America Reservoir Membrane Patches Market by Country
8.4 North America Microneedle Patches Market by Country
8.5 North America Iontophoresis Patches Market by Country
8.6 North America Vapour Patches Market by Country
Chapter 9. North America Transdermal Patches Market by Application
9.1 North America Pain Management Market by Country
9.2 North America Smoking Cessation Market by Country
9.3 North America Hormone Replacement Therapy Market by Country
9.4 North America Cardiovascular Disorder Market by Country
9.5 North America Central Nervous System Disorder Market by Country
9.6 North America Others Market by Country
Chapter 10. North America Transdermal Patches Market by Country
10.1 US Transdermal Patches Market
10.1.1 US Transdermal Patches Market by End User
10.1.2 US Transdermal Patches Market by Distribution Channel
10.1.3 US Transdermal Patches Market by Adhesive Type
10.1.4 US Transdermal Patches Market by Patch Type
10.1.5 US Transdermal Patches Market by Application
10.2 Canada Transdermal Patches Market
10.2.1 Canada Transdermal Patches Market by End User
10.2.2 Canada Transdermal Patches Market by Distribution Channel
10.2.3 Canada Transdermal Patches Market by Adhesive Type
10.2.4 Canada Transdermal Patches Market by Patch Type
10.2.5 Canada Transdermal Patches Market by Application
10.3 Mexico Transdermal Patches Market
10.3.1 Mexico Transdermal Patches Market by End User
10.3.2 Mexico Transdermal Patches Market by Distribution Channel
10.3.3 Mexico Transdermal Patches Market by Adhesive Type
10.3.4 Mexico Transdermal Patches Market by Patch Type
10.3.5 Mexico Transdermal Patches Market by Application
10.4 Rest of North America Transdermal Patches Market
10.4.1 Rest of North America Transdermal Patches Market by End User
10.4.2 Rest of North America Transdermal Patches Market by Distribution Channel
10.4.3 Rest of North America Transdermal Patches Market by Adhesive Type
10.4.4 Rest of North America Transdermal Patches Market by Patch Type
10.4.5 Rest of North America Transdermal Patches Market by Application
Chapter 11. Company Profiles
11.1 Johnson & Johnson
11.1.1 Company Overview
11.1.2 Financial Analysis
11.1.3 Segmental and Regional Analysis
11.1.4 Research & Development Expenses
11.1.5 SWOT Analysis
11.2 Viatris, Inc. (Mylan N.V.)
11.2.1 Company Overview
11.2.2 Financial Analysis
11.2.3 Segmental Analysis
11.2.4 Research & Development Expense
11.2.5 Recent strategies and developments:
11.2.5.1 Partnerships, Collaborations, and Agreements:
11.2.6 SWOT Analysis
11.3 Boehringer Ingelheim International GmbH
11.3.1 Company Overview
11.3.2 Financial Analysis
11.3.3 Regional & Segmental Analysis
11.3.4 Research & Development Expenses
11.3.5 SWOT Analysis
11.4 Endo International PLC
11.4.1 Company Overview
11.4.2 Financial Analysis
11.4.3 Segmental Analysis
11.4.4 Research & Development Expense
11.4.5 SWOT Analysis
11.5 Bayer AG
11.5.1 Company Overview
11.5.2 Financial Analysis
11.5.3 Segmental and Regional Analysis
11.5.4 Research & Development Expense
11.5.5 SWOT Analysis
11.6 Nitto Denko Corporation
11.6.1 Company Overview
11.6.2 Financial Analysis
11.6.3 Segmental Analysis
11.6.4 Research & Development Expense
11.6.5 SWOT Analysis
11.7 Cipla Limited
11.7.1 Company Overview
11.7.2 Financial Analysis
11.7.3 Segmental and Regional Analysis
11.7.4 Research & Development Expense
11.7.5 Recent strategies and developments:
11.7.5.1 Acquisition and Mergers:
11.7.6 SWOT Analysis
11.8 Amneal Pharmaceuticals, Inc.
11.8.1 Company Overview
11.8.2 Financial Analysis
11.8.3 Segmental Analysis
11.8.4 Research & Development Expenses
11.8.5 Recent strategies and developments:
11.8.5.1 Product Launches and Product Expansions:
11.8.6 SWOT Analysis
11.9 Novartis AG
11.9.1 Company Overview
11.9.2 Financial Analysis
11.9.3 Segmental and Regional Analysis
11.9.4 Research & Development Expense
11.9.5 SWOT Analysis
11.10. AbbVie, Inc.
11.10.1 Company Overview
11.10.2 Financial Analysis
11.10.3 Regional Analysis
11.10.4 Research & Development Expense
11.10.5 SWOT Analysis
Unique Offerings 